We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Positive Angle Kappa

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01644552
First Posted: July 19, 2012
Last Update Posted: July 19, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
  Purpose
Patients with aniridia have positive angle kappas.

Condition
Aniridia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Positive Angle Kappa: a Sign in Aniridia

Resource links provided by NLM:


Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Enrollment: 16
Study Start Date: August 2010
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
eye examinations

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Month to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients with aniridia
Criteria

Inclusion Criteria:

  • patients with aniridia only

Exclusion Criteria:

  • poor va
  • PK,
  • K-pro
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01644552


Locations
United States, Minnesota
University of Minnesota Dept of ophthalmlogy
Minneapolis,, Minnesota, United States, 55455
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
  More Information

Responsible Party: University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier: NCT01644552     History of Changes
Other Study ID Numbers: kmerrill
First Submitted: February 20, 2012
First Posted: July 19, 2012
Last Update Posted: July 19, 2012
Last Verified: July 2012

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
aniridia
positive angle kappa

Additional relevant MeSH terms:
Aniridia
Eye Abnormalities
Eye Diseases
Eye Diseases, Hereditary
Iris Diseases
Uveal Diseases
Congenital Abnormalities
Genetic Diseases, Inborn